Heavy Pharmaceutical Holdings: 2021 Annual Equity Distribution Implementation Notice
Heavy Pharmaceutical Holdings: Announcement on the financing plans for subsidiaries affiliated with Heavy Pharmaceutical Co., Ltd. in 2022
Heavy Pharmaceutical Holdings: Announcement on the 2022 Annual Financing Plan
Heavy Pharmaceutical Holdings: Announcement on the results of issuing the first issue of 2022 interim notes by the holding subsidiary
Heavy Pharmaceutical Holdings: Announcement on the results of issuing the second instalment of ultra-short-term financing notes for the holding subsidiary in 2022
Heavy Pharmaceutical Holdings: Progress announcement on the acquisition of the 36% partnership share and related transactions of Chongqing Chemical Pharmaceutical Holdings (Group) Company in Chongqing and Asia Chemical Venture Capital Partnership (Limited
Heavy Pharmaceutical Holdings: Announcement on the results of the issuance of the 12th batch of ultra-short-term financing notes by the holding subsidiary in 2021
Heavy Pharmaceutical Holdings: Progress announcement on the acquisition of the 36% partnership share and related transactions of Chongqing Chemical Pharmaceutical Holdings (Group) Company in Chongqing and Asia Chemical Venture Capital Partnership (Limited
Heavy Pharmaceutical Holdings: Announcement on the results of the issuance of the 11th ultra-short-term financing notes for the holding subsidiary in 2021
Heavy Pharmaceutical Holdings: Announcement on the results of the issuance of the eighth instalment of ultra-short-term financing notes by the holding subsidiary in 2021
Heavy Pharmaceutical Holdings: Announcement on the progress of Chongqing Pharmaceutical (Group) Co., Ltd. bidding for 10% of the shares and related transactions of Chongqing Chemical Medicine Holding Group Finance Co., Ltd. held by Heavy Pharmaceutical Gro
Heavy Pharmaceutical Holdings: Announcement on the company's holding subsidiary's intention to issue perpetual medium-term notes or renewable bond products
Heavy Pharmaceutical Holdings: Announcement on the results of issuing the second instalment of ultra-short-term financing notes for the holding subsidiary in 2021
Heavy Pharmaceutical Holdings: Announcement on the transfer of shares of the holding subsidiary Chongqing Pharmaceutical Group Dazu Hospital Management Co., Ltd.
Heavy Pharmaceutical Holdings: Announcement on the holding subsidiary's acquisition of 51% of the shares of Chongqing Changsheng Pharmaceutical Co., Ltd.
Heavy Pharmaceutical Holdings: An indicative announcement on the sale of major assets and the lifting of the ban on restricted shares to purchase assets and related transactions
Heavy Pharmaceutical Holdings: Announcement on the results of the issuance of the fourth instalment of ultra-short-term financing notes by the holding subsidiary in 2020
Heavy Pharmaceutical Holdings: Announcement on the results of issuing the first batch of interim notes in 2020 by the holding subsidiary
Heavy Pharmaceutical Holdings: Announcement on the holding subsidiary's acquisition of shares in Tianjin Tianshili Pharmaceutical Marketing Group Co., Ltd.
Heavy Pharmaceutical Holdings: Announcement on the progress of Chongqing Pharmaceutical (Group) Co., Ltd. bidding for 10% of the shares and related transactions of Chongqing Chemical Medicine Holding Group Finance Co., Ltd. held by Heavy Pharmaceutical Gro
No Data